Correlation Between Waters and Hookipa Pharma
Can any of the company-specific risk be diversified away by investing in both Waters and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Waters and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Waters and Hookipa Pharma, you can compare the effects of market volatilities on Waters and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Waters with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Waters and Hookipa Pharma.
Diversification Opportunities for Waters and Hookipa Pharma
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Waters and Hookipa is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Waters and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Waters is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Waters are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Waters i.e., Waters and Hookipa Pharma go up and down completely randomly.
Pair Corralation between Waters and Hookipa Pharma
Considering the 90-day investment horizon Waters is expected to generate 0.37 times more return on investment than Hookipa Pharma. However, Waters is 2.72 times less risky than Hookipa Pharma. It trades about -0.01 of its potential returns per unit of risk. Hookipa Pharma is currently generating about -0.15 per unit of risk. If you would invest 37,094 in Waters on December 28, 2024 and sell it today you would lose (878.00) from holding Waters or give up 2.37% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Waters vs. Hookipa Pharma
Performance |
Timeline |
Waters |
Hookipa Pharma |
Waters and Hookipa Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Waters and Hookipa Pharma
The main advantage of trading using opposite Waters and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Waters position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.Waters vs. IDEXX Laboratories | Waters vs. IQVIA Holdings | Waters vs. Charles River Laboratories | Waters vs. Revvity |
Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Stocks Directory Find actively traded stocks across global markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Equity Valuation Check real value of public entities based on technical and fundamental data |